| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/22/2022 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 104.9k | $8.45 | $886.6k | | 06/22/2022 |
| 06/17/2021 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 38.9k | $62.63 | $2.4M | | 06/17/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 21.5k | $48.51 | $1M | | 01/26/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 21.5k | $30.87 | $664.6k | | 01/26/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 43.1k | $20.34 | $875.8k | | 01/26/2021 |
| 01/26/2021 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 39.9k | $26.21 | $1M | | 01/26/2021 |
| 01/26/2021 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 39.9k | $16.68 | $664.7k | | 01/26/2021 |
| 01/26/2021 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 79.7k | $10.99 | $875.9k | | 01/26/2021 |
| 06/02/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 112.4k | $29.00 | $3.3M | | 06/02/2020 |
| 05/27/2020 | Eidos Therapeutics, Inc. | EIDX | Grant | Stock Option (right to buy) | 21.5k | $48.51 | $1M | | 05/27/2020 |
| 01/10/2020 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $17.73 | $354.6k | | 01/10/2020 |
| 12/12/2019 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 82.9k | $37.45 | $3.1M | | 12/12/2019 |
| 07/03/2019 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 882.4k | $29.90 | $26.4M | See Footnote | 07/03/2019 |
| 06/12/2019 | Eidos Therapeutics, Inc. | EIDX | Grant | Stock Option (right to buy) | 21.5k | $30.87 | $664.6k | | 06/12/2019 |
| 05/24/2019 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 1.1M | $25.93 | $28.6M | See Footnote | 05/24/2019 |
| 01/11/2019 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $12.37 | $247.4k | | 01/11/2019 |
| 07/01/2018 | Eidos Therapeutics, Inc. | EIDX | Grant | Stock Option (right to buy) | 43.1k | $20.34 | $875.8k | | 07/01/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Conversion | Common Stock | 18.8M | $0.00 | $0 | See footnote | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Payment of Exercise | Common Stock | 211.8k | $17.00 | $3.6M | See footnote | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 1000k | $17.00 | $17M | See footnote | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Exercise (in-the-money or at-the-money) | Warrants | 332.3k | $10.83 | $3.6M | See footnote | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Exercise (in-the-money or at-the-money) | Series B Convertible Preferred Stock | 332.3k | $0.00 | $0 | See footnote | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Conversion | Series B Convertible Preferred Stock | 2.9M | $0.00 | $0 | See footnote | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Conversion | Series Seed Preferred Stock | 12.8M | $0.00 | $0 | See footnote | 06/22/2018 |
| 02/01/2018 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $10.05 | $201k | | 02/01/2018 |
| 05/17/2017 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 20k | $23.80 | $476k | | 05/17/2017 |
| 05/24/2016 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 10k | $18.28 | $182.8k | | 05/24/2016 |